Drug
Salmeterol Fluticasone Easyhaler
Salmeterol Fluticasone Easyhaler: highest development phase Phase 1, developed by Orion Corporation. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Orion Corporation
Trials
| Drug | Phase | Indication |
|---|---|---|
| Salmeterol/fluticasone Easyhaler NCT02162485 | Phase 1 | Asthma |
Latest
No recent events.
Follow Salmeterol Fluticasone Easyhaler on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.